Noninvasive glucose monitor

Last updated
Non-invasive glucose monitor
Purposemeasurement of blood glucose levels

Noninvasive glucose monitoring (NIGM) is the measurement of blood glucose levels, required by people with diabetes to prevent both chronic and acute complications from the disease, without drawing blood, puncturing the skin, or causing pain or trauma. The search for a successful technique began about 1975 and has continued to the present without a clinically or commercially viable product. [1]

History

As of 1999, only one such product had been approved for sale by the FDA, based on a technique for electrically pulling glucose through intact skin, and it was withdrawn after a short time owing to poor performance and occasional damage to the skin of users. [2]

Hundreds of millions of dollars have been invested in companies who have sought the solution to this long-standing problem. Approaches that have been tried include near-infrared spectroscopy (NIRS, measuring glucose through the skin using light of slightly longer wavelengths than the visible region), [3] transdermal measurement (attempting to pull glucose through the skin using either chemicals, electricity or ultrasound), measuring the amount that polarized light is rotated by glucose in the front chamber of the eye (containing the aqueous humor), and many others.

A 2012 study reviewed ten technologies: bioimpedance spectroscopy, microwave/RF sensing, [4] [5] fluorescence technology, mid-infrared spectroscopy, near-infrared spectroscopy, optical coherence tomography, optical polarimetry, Raman spectroscopy, reverse iontophoresis, and ultrasound technology, concluding with the observation that none of these had produced a commercially available, clinically reliable device and that therefore, much work remained to be done. [6]

As of 2014, disregarding the severe shortcomings mentioned above, at least one non-invasive glucose meter was being marketed in a number of countries. [7] [8] Still, as the mean absolute deviation of this device was nearly 30% in clinical trials, "further research efforts were desired to significantly improve the accuracy [...]". [9]

While multiple technologies have been tried, Raman spectroscopy has gained traction as one promising technology for measuring glucose in interstitial fluid. Early attempts include C8 Medisensors [10] and the Laser Biomedical Research Center at Massachusetts Institute of Technology (MIT) which have been working on a Raman spectroscopy sensor for more than 20 years and conducting clinical investigations in collaboration with the Clinical Research Center at University of Missouri, Columbia, US. [11] In 2018 a paper in PLOS ONE showed independent validation data from a clinical investigation comprising 15 subjects with diabetes mellitus type 1 with a mean absolute relative difference (MARD) of 25.8%. [12] The system used, was a custom-built confocal Raman setup. In 2019 researchers at the Samsung Advanced Institute of Technology (SAIT), Samsung Electronics, in collaboration with the Laser Biomedical Research Center MIT developed a new approach based on Raman spectroscopy that allowed them to see the glucose signal directly. The researchers tested the system in pigs and could get accurate glucose readings for up to an hour after initial calibration. [13]

In 2020, German Institute for Diabetes-Technology published data from 15 subjects with type 1 diabetes on a new prototype GlucoBeam based on Raman spectroscopy from RSP Systems Denmark, showing a MARD of 23.6% on independent validation in out-patient setup with up till 8 days without recalibration. [14]

With accuracy on marketed BGM devices in the US between 5.6 and 20.8%. [15] A NIGM solution would likely need to have an accuracy with a MARD below 20% to be widely accepted.

The number of clinical trials of non-invasive glucose monitors has grown throughout the 21st century. While the National Institutes of Health recorded only 4 clinical investigations of the technology from 2000 to 2015, there were 16 from 2016 to 2020. [16]

Related Research Articles

<span class="mw-page-title-main">Blood glucose monitoring</span> Use of a glucose monitor for testing the concentration of glucose in the blood

Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood (glycemia). Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The other main option is continuous glucose monitoring (CGM). Different manufacturers use different technology, but most systems measure an electrical characteristic and use this to determine the glucose level in the blood. Skin-prick methods measure capillary blood glucose, whereas CGM correlates interstitial fluid glucose level to blood glucose level. Measurements may occur after fasting or at random nonfasting intervals, each of which informs diagnosis or monitoring in different ways.

<span class="mw-page-title-main">Pulse oximetry</span> Measurement of blood oxygen saturation

Pulse oximetry is a noninvasive method for monitoring a person's blood oxygen saturation. Peripheral oxygen saturation (SpO2) readings are typically within 2% accuracy of the more accurate reading of arterial oxygen saturation (SaO2) from arterial blood gas analysis. But the two are correlated well enough that the safe, convenient, noninvasive, inexpensive pulse oximetry method is valuable for measuring oxygen saturation in clinical use.

<span class="mw-page-title-main">Near-infrared spectroscopy</span> Analytical method

Near-infrared spectroscopy (NIRS) is a spectroscopic method that uses the near-infrared region of the electromagnetic spectrum. Typical applications include medical and physiological diagnostics and research including blood sugar, pulse oximetry, functional neuroimaging, sports medicine, elite sports training, ergonomics, rehabilitation, neonatal research, brain computer interface, urology, and neurology. There are also applications in other areas as well such as pharmaceutical, food and agrochemical quality control, atmospheric chemistry, combustion research and knowledge.

<span class="mw-page-title-main">Glucose meter</span> Medical device for determining the concentration of glucose in the blood

A glucose meter, also referred to as a "glucometer", is a medical device for determining the approximate concentration of glucose in the blood. It can also be a strip of glucose paper dipped into a substance and measured to the glucose chart. It is a key element of glucose testing, including home blood glucose monitoring (HBGM) performed by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained from slightly piercing a fingertip with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in units of mg/dL or mmol/L.

<span class="mw-page-title-main">Functional near-infrared spectroscopy</span> Optical technique for monitoring brain activity

Functional near-infrared spectroscopy (fNIRS) is an optical brain monitoring technique which uses near-infrared spectroscopy for the purpose of functional neuroimaging. Using fNIRS, brain activity is measured by using near-infrared light to estimate cortical hemodynamic activity which occur in response to neural activity. Alongside EEG, fNIRS is one of the most common non-invasive neuroimaging techniques which can be used in portable contexts. The signal is often compared with the BOLD signal measured by fMRI and is capable of measuring changes both in oxy- and deoxyhemoglobin concentration, but can only measure from regions near the cortical surface. fNIRS may also be referred to as Optical Topography (OT) and is sometimes referred to simply as NIRS.

Automated insulin delivery systems are automated systems designed to assist people with insulin-requiring diabetes, by automatically adjusting insulin delivery in response to blood glucose levels. Currently available systems can only deliver a single hormone—insulin. Other systems currently in development aim to improve on current systems by adding one or more additional hormones that can be delivered as needed, providing something closer to the endocrine functionality of the pancreas.

Sudomotor function refers to the autonomic nervous system control of sweat gland activity in response to various environmental and individual factors. Sweat production is a vital thermoregulatory mechanism used by the body to prevent heat-related illness as the evaporation of sweat is the body’s most effective method of heat reduction and the only cooling method available when the air temperature rises above skin temperature. In addition, sweat plays key roles in grip, microbial defense, and wound healing.

<span class="mw-page-title-main">Masimo</span> American healthcare company

Masimo Corporation is an Irvine, California-based global medical technology company that develops, manufactures, and markets non-invasive patient monitoring technologies, hospital automation solutions, home monitoring devices, ventilation solutions, and consumer products. The company's core measurement technologies are pulse oximetry, alongside advanced Pulse CO-Oximetry measurements, brain function monitoring, regional oximetry, acoustic respiration rate monitoring, capnography, nasal high-flow respiratory support therapy, patient position and activity tracking, and neuromodulation technology for the reduction of symptoms associated with opioid withdrawal.

Carbon nanotubes (CNTs) are very prevalent in today's world of medical research and are being highly researched in the fields of efficient drug delivery and biosensing methods for disease treatment and health monitoring. Carbon nanotube technology has shown to have the potential to alter drug delivery and biosensing methods for the better, and thus, carbon nanotubes have recently garnered interest in the field of medicine.

<span class="mw-page-title-main">Minimed Paradigm</span> Insulin pumps

MiniMed Paradigm is a series of insulin pumps manufactured by Medtronic for patients with diabetes mellitus. The pump operates with a single AAA battery and uses a piston-plunger pump to infuse a programmed amount of insulin into the patient through a length of tubing. The Paradigm uses a one-way wireless radio frequency link to receive blood sugar measurements from select glucose meters. The Paradigm RT series adds the ability to receive data from a mated continuous blood-glucose monitor. Although the pump can use these measurements to assist in calculating a dose of insulin, no actual change in insulin delivery occurs without manual user-intervention.

<span class="mw-page-title-main">Monitoring (medicine)</span> Observation of a disease, condition or one or several medical parameters over time

In medicine, monitoring is the observation of a disease, condition or one or several medical parameters over time.

Google Contact Lens was a smart contact lens project announced by Google on 16 January 2014. The project aimed to assist people with diabetes by constantly measuring the glucose levels in their tears. The project was being carried out by Verily and as of 2014 was being tested using prototypes. On November 16, 2018, Verily announced it had discontinued the project.

<span class="mw-page-title-main">Blood pressure measurement</span> Techniques for determining blood pressure

Arterial blood pressure is most commonly measured via a sphygmomanometer, which historically used the height of a column of mercury to reflect the circulating pressure. Blood pressure values are generally reported in millimetres of mercury (mmHg), though aneroid and electronic devices do not contain mercury.

Ambulatory glucose profile (AGP) is a single-page, standardized report for interpreting a patient's daily glucose and insulin patterns. AGP provides both graphic and quantitative characterizations of daily glucose patterns. First developed by Drs. Roger Mazze and David Rodbard, with colleagues at the Albert Einstein College of Medicine in 1987, AGP was initially used for the representation of episodic self-monitored blood glucose (SMBG). The first version included a glucose median and inter-quartile ranges graphed as a 24-hour day. Dr. Mazze brought the original AGP to the International Diabetes Center (IDC) in the late 1980s. Since then, IDC has built the AGP into the internationally recognized standard for glucose pattern reporting.

GlySens, a biomedical technology company, is a privately owned corporation developing a long term internal continuous glucose monitor in order to effectively manage and observe glucose levels in real time. The GlySens ICGM system is the world's first surgically implanted continuous glucose monitoring system to demonstrate an 18-month performance in a preclinical setting. GlySens Incorporated was founded in 1998 by David A. Gough and Joseph Lucisano, a bioengineering graduate at the University of California, San Diego. The implanted continuous glucose monitoring system uses an internal sensor equipped with electrochemical detectors to measure glucose readings via a chemical reaction between enzymes and oxygen.

The Beckman Laser Institute is an interdisciplinary research center for the development of optical technologies and their use in biology and medicine. Located on the campus of the University of California, Irvine in Irvine, California, an independent nonprofit corporation was created in 1982, under the leadership of Michael W. Berns, and the actual facility opened on June 4, 1986. It is one of a number of institutions focused on translational research, connecting research and medical applications. Researchers at the institute have developed laser techniques for the manipulation of structures within a living cell, and applied them medically in treatment of skin conditions, stroke, and cancer, among others.

<span class="mw-page-title-main">Continuous glucose monitor</span> Blood glucose monitoring device

A continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis instead of monitoring glucose levels periodically by drawing a drop of blood from a finger. CGMs are used by people who treat their diabetes with insulin, for example people with type I diabetes, type II diabetes, or other types of diabetes, such as gestational diabetes.

Bioinstrumentation or Biomedical Instrumentation is an application of biomedical engineering, which focuses on development of devices and mechanics used to measure, evaluate, and treat biological systems. The goal of biomedical instrumentation focuses on the use of multiple sensors to monitor physiological characteristics of a human or animal for diagnostic and disease treatment purposes. Such instrumentation originated as a necessity to constantly monitor vital signs of Astronauts during NASA's Mercury, Gemini, and Apollo missions.

<span class="mw-page-title-main">Anita Mahadevan-Jansen</span> Biomedical engineer

Anita Mahadevan-Jansen is a Professor of Biomedical Engineering and holds the Orrin H. Ingram Chair in Biomedical Engineering at Vanderbilt University. Her research considers the development of optical techniques for clinical diagnosis and surgical guidance, particularly using Raman and fluorescence spectroscopy. She serves on the Board of Directors of SPIE, and is a Fellow of SPIE, The Optical Society, Society for Applied Spectroscopy, and the American Society for Lasers in Medicine and Surgery. She was elected to serve as the 2020 Vice President of SPIE. With her election, Mahadevan-Jansen joined the SPIE presidential chain and served as President-Elect in 2021 and the Society's President in 2022.

References

  1. ↑ The Pursuit of Noninvasive Glucose, 7th Edition, by John L. Smith, Ph.D.
  2. ↑ Tamada JA, Garg S, Jovanovic L, Pitzer KR, Fermi S, Potts RO (November 1999). "Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team". JAMA. 282 (19): 1839–44. doi:10.1001/jama.282.19.1839. PMID   10573275.
  3. ↑ Ahmad M, Kamboh A, Khan A (16 October 2013). "Non-invasive blood glucose monitoring using near-infrared spectroscopy". EDN Network.
  4. ↑ Huang SY, Yoshida Y, Inda AJ, Xavier CX, Mu WC, Meng YS, Yu W (October 2018). "Microstrip line-based glucose sensor for noninvasive continuous monitoring using the main field for sensing and multivariable crosschecking". IEEE Sensors Journal. 19 (2): 535–47. Bibcode:2019ISenJ..19..535H. doi:10.1109/JSEN.2018.2877691. S2CID   56719208.
  5. ↑ Yu W, Huang SY (October 2018). "T-Shaped Patterned Microstrip Line for Noninvasive Continuous Glucose Sensing". IEEE Microwave and Wireless Components Letters. 28 (10): 942–4. doi:10.1109/LMWC.2018.2861565. S2CID   52932653.
  6. ↑ So CF, Choi KS, Wong TK, Chung JW (June 29, 2012). "Recent advances in noninvasive glucose monitoring". Medical Devices: Evidence and Research. 5: 45–52. doi: 10.2147/MDER.S28134 . PMC   3500977 . PMID   23166457.
  7. ↑ "Distributors | GlucoTrack".
  8. ↑ "Cnoga Medical".
  9. ↑ Vashist SK (October 2013). "Continuous Glucose Monitoring Systems: A Review". Diagnostics. 3 (4): 385–412. doi: 10.3390/diagnostics3040385 . PMC   4665529 . PMID   26824930.
  10. ↑ Lipson J, Bernhardt J, Block U, Freeman WR, Hofmeister R, Hristakeva M, et al. (March 2009). "Requirements for calibration in noninvasive glucose monitoring by Raman spectroscopy". Journal of Diabetes Science and Technology. 3 (2): 233–41. doi:10.1177/193229680900300203. PMC   2771519 . PMID   20144354.
  11. ↑ Singh SP, Mukherjee S, Galindo LH, So PT, Dasari RR, Khan UZ, et al. (October 2018). "Evaluation of accuracy dependence of Raman spectroscopic models on the ratio of calibration and validation points for non-invasive glucose sensing". Analytical and Bioanalytical Chemistry. 410 (25): 6469–6475. doi:10.1007/s00216-018-1244-y. PMC   6128756 . PMID   30046865.
  12. ↑ Lundsgaard-Nielsen SM, Pors A, Banke SO, Henriksen JE, Hepp DK, Weber A (2018). "Critical-depth Raman spectroscopy enables home-use non-invasive glucose monitoring". PLOS ONE. 13 (5): e0197134. Bibcode:2018PLoSO..1397134L. doi: 10.1371/journal.pone.0197134 . PMC   5947912 . PMID   29750797.
  13. ↑ Kang JW, Park YS, Chang H, Lee W, Singh SP, Choi W, et al. (January 2020). "Direct observation of glucose fingerprint using in vivo Raman spectroscopy". Science Advances. 6 (4): eaay5206. Bibcode:2020SciA....6.5206K. doi: 10.1126/sciadv.aay5206 . PMC   6981082 . PMID   32042901.
  14. ↑ Pleus S, Schauer S, Jendrike N, Zschornack E, Link M, Hepp KD, et al. (August 2020). "Proof of Concept for a New Raman-Based Prototype for Noninvasive Glucose Monitoring". Journal of Diabetes Science and Technology. 15 (1): 11–18. doi:10.1177/1932296820947112. PMC   7783007 . PMID   32783466.
  15. ↑ Ekhlaspour L, Mondesir D, Lautsch N, Balliro C, Hillard M, Magyar K, et al. (May 2017). "Comparative Accuracy of 17 Point-of-Care Glucose Meters". Journal of Diabetes Science and Technology. 11 (3): 558–566. doi:10.1177/1932296816672237. PMC   5505415 . PMID   27697848.
  16. ↑ "ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2020-08-28.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.